LTRN icon

Lantern Pharma
LTRN

Overview Fund Activity

21 hedge funds and large institutions have $5.14M invested in Lantern Pharma in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
-2
Holders Change %
-8.7%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
6
Closed
6
Calls
$58K
Puts
$2K
Net Calls
+$56K
Net Calls Change
+$15K

Top Buyers

1
HKAM
Horizon Kinetics Asset Management
New York
$145K
2
UBS Group
UBS Group
Switzerland
$130K
3
Renaissance Technologies
Renaissance Technologies
New York
$119K
4
TRCT
Tower Research Capital (TRC)
New York
$10K
5
CWM
Cranbrook Wealth Management
Michigan
$3.46K

Top Sellers

1
Jane Street
Jane Street
New York
$0
2
LCM
Lynwood Capital Management
Ontario, Canada
$0
3
CC
Carlson Capital
Texas
$603K
4
Citadel Advisors
Citadel Advisors
Florida
$53K
5
RAM
Redmond Asset Management
Virginia
$238K
Name Holding Trade Value Shares
Change 		Shares
Change %
Morgan Stanley
26
Morgan Stanley
New York
– -$1.75K -289 Closed
Bank of America
27
Bank of America
North Carolina
– -$48 -8 Closed
1
2